F. Wendling et al., MPLV: a retrovirus complex inducing an acute myeloproliferative leukemic disorder in adult mice. Virology. 149(2), 242–246 (1986)

Article  PubMed  CAS  Google Scholar 

Y.C. Chia et al., Molecular genetics of thrombotic myeloproliferative neoplasms: implications in precision oncology. Diagnostics. 13(1), 163 (2023)

Article  PubMed  PubMed Central  CAS  Google Scholar 

I. Vigon et al., Molecular cloning and characterization of c-MPL, the human homolog of the v-MPL oncogene: identification of a member of the hematopoietic growth factor receptor superfamily. Proc. Natl. Acad. Sci. 89(12), 5640–5644 (1992)

Article  PubMed  PubMed Central  CAS  Google Scholar 

A. Roy et al., In and out: traffic and dynamics of thrombopoietin receptor. J. Cell Mol. Med. 25(19), 9073–9083 (2021)

Article  PubMed  PubMed Central  CAS  Google Scholar 

V. Mignotte et al., Structure and transcription of the human c-MPL gene (c-MPL). Genomics. 20(1), 5–12 (1994)

Article  PubMed  CAS  Google Scholar 

B. Wang, H. Mehta, Cytokine receptor splice variants in hematologic diseases. Cytokine. 127, 154919 (2020)

Article  PubMed  CAS  Google Scholar 

I.S. Hitchcock et al., The thrombopoietin receptor: revisiting the master regulator of platelet production. Platelets. 32(6), 770–778 (2021)

Article  PubMed  PubMed Central  CAS  Google Scholar 

M.D. Feese et al., Structure of the receptor-binding domain of human thrombopoietin determined by complexation with a neutralizing antibody fragment. Proc. Natl. Acad. Sci. 101(7), 1816–1821 (2004)

Article  PubMed  PubMed Central  CAS  Google Scholar 

D.F. Sabath et al., Deletion of the extracellular membrane-distal cytokine receptor homology module of Mpl results in constitutive cell growth and loss of thrombopoietin binding. Blood J. Am. Soc. Hematol. 94(1), 365–367 (1999)

CAS  Google Scholar 

L.N. Varghese et al., Functional characterization of c-Mpl ectodomain mutations that underlie congenital amegakaryocytic thrombocytopenia. Growth Factors 32(1), 18–26 (2014)

Article  PubMed  CAS  Google Scholar 

A.L. Gurney et al., Genomic structure, chromosomal localization, and conserved alternative splice forms of thrombopoietin. 981–988 (1995)

F.A. Bhat et al., A network map of thrombopoietin signaling. J. Cell Commun. Signal. 12, 737–743 (2018)

Article  PubMed  PubMed Central  Google Scholar 

D. Cosman et al., A new cytokine receptor superfamily. Trends Biochem. Sci. 15(7), 265–270 (1990)

Article  PubMed  CAS  Google Scholar 

D.J. Hilton et al., Saturation mutagenesis of the WSXWS motif of the erythropoietin receptor. J. Biol. Chem. 271(9), 4699–4708 (1996)

Article  PubMed  CAS  Google Scholar 

R. Dagil et al., The WSXWS motif in cytokine receptors is a molecular switch involved in receptor activation: insight from structures of the prolactin receptor. Structure. 20(2), 270–282 (2012)

Article  PubMed  CAS  Google Scholar 

J. Staerk et al., An amphipathic motif at the transmembrane-cytoplasmic junction prevents autonomous activation of the thrombopoietin receptor. Blood. 107(5), 1864–1871 (2006)

Article  PubMed  PubMed Central  CAS  Google Scholar 

L.N. Varghese et al., The thrombopoietin receptor: structural basis of traffic and activation by ligand, mutations, agonists, and mutated calreticulin. Front. Endocrinol. 8, 59 (2017)

Article  Google Scholar 

S.N. Constantinescu et al., The erythropoietin receptor cytosolic juxtamembrane domain contains an essential, precisely oriented, hydrophobic motif. Mol. Cell. 7(2), 377–385 (2001)

Article  PubMed  CAS  Google Scholar 

R. Ren et al., Identification of a ten-amino acid proline-rich SH3 binding site. Science. 259(5098), 1157–1161 (1993)

Article  PubMed  CAS  Google Scholar 

M.L. Choong et al., Combination treatment for myeloproliferative neoplasms using JAK and pan-class I PI 3K inhibitors. J. Cell Mol. Med. 17(11), 1397–1409 (2013)

Article  PubMed  PubMed Central  CAS  Google Scholar 

L. Benit et al., Characterization of mpl cytoplasmic domain sequences required for myeloproliferative leukemia virus pathogenicity. J. Virol. 68(8), 5270–5274 (1994)

Article  PubMed  PubMed Central  CAS  Google Scholar 

F. Li et al., c-Mpl-del, a c-Mpl alternative splicing isoform, promotes AMKL progression and chemoresistance. Cell Death Dis. 13(10), 869 (2022)

Article  PubMed  PubMed Central  CAS  Google Scholar 

J.G. Drachman, K. Kaushansky, Dissecting the thrombopoietin receptor: functional elements of the Mpl cytoplasmic domain. Proc. Natl. Acad. Sci. 94(6), 2350–2355 (1997)

Article  PubMed  PubMed Central  CAS  Google Scholar 

G. Millot et al., MPLK, a natural variant of the thrombopoietin receptor with a truncated cytoplasmic domain, binds thrombopoietin but does not interfere with thrombopoietin-mediated cell growth. Exp. Hematol. 30(2), 166–175 (2002)

Article  PubMed  CAS  Google Scholar 

J.Y. Noh, Megakaryopoiesis and platelet biology: roles of transcription factors and emergingclinical implications. Int. J. Mol. Sci. 22(17), 9615 (2021)

Article  PubMed  PubMed Central  CAS  Google Scholar 

H. Minamiguchi et al., Simultaneous signalling through c-mpl, c-kit, and CXCR4 enhances the proliferation and differentiation of human megakaryocyte progenitors: possible roles of the PI3-K, PKC and MAPK pathways. Br. J. Haematol. 115(1), 175–185 (2001)

Article  PubMed  CAS  Google Scholar 

Z. Li, B. Riesenberg, A. Metelli, A. Li, B.X. Wu, The role of platelets in tumour growth, metastasis, and immune evasion. InPlatelets (Academic Press, 2019), pp. 547–561

J. Pinilla-Ibarz, K.L. Sweet, G.M. Corrales-Yepez, R.S. Komrokji, Role of tyrosine-kinase inhibitors in myeloproliferative neoplasms: comparative lessons learned. OncoTargets Ther. 10, 4937–4957 (2016)

Google Scholar 

L.J. Alvarado, A. Andreoni, H.D. Huntsman, H. Cheng, J.R. Knutson, A. Larochelle, Heterodimerization of TPO and IFNγ impairs human hematopoietic stem/progenitor cell signalling and survival in chronic inflammation. Blood. 130, 4 (2017)

Google Scholar 

K. Kaushansky, Molecular mechanisms of thrombopoietin signaling. J. Thromb. Haemost. 7, 235–238 (2009)

Article  PubMed  CAS  Google Scholar 

C.D. Nishimura, D.A. Brenner, M. Mukherjee, R.A. Hirsch, L. Ott, M.F. Wu, H. Liu, O. Dakhova, J.S. Orange, M.K. Brenner, C.Y. Lin, c-MPL provides tumour-targeted T-cell receptor-transgenic T cells with costimulation and cytokine signals. Blood J. Am. Soc. Hematol. 130(25), 2739–2749 (2017)

CAS  Google Scholar 

A.I. Schafer, Thrombocytosis. N. Engl. J. Med. 350(12), 1211–1219 (2004)

Article  PubMed  CAS  Google Scholar 

J.M. Ninos, L.C. Jefferies, C.R. Cogle, W.G. Kerr, The thrombopoietin receptor, c-Mpl, is a selective surface marker for human hematopoietic stem cells. J. Transl. Med. 4, 1–8 (2006)

Article  Google Scholar 

R.C. Skoda et al., Murine c-MPL: a member of the hematopoietic growth factor receptor superfamily that transduces a proliferative signal. EMBO J. 12(7), 2645–2653 (1993)